Ignite Creation Date:
2025-12-24 @ 7:34 PM
Ignite Modification Date:
2026-01-17 @ 12:12 PM
Study NCT ID:
NCT02085603
Status:
COMPLETED
Last Update Posted:
2018-04-13
First Post:
2014-03-11
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
SarCaBon: A Randomised Phase II Trial of Saracatinib Versus Placebo for Cancer-induced Bone Pain
Sponsor:
Sheffield Teaching Hospitals NHS Foundation Trust
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2014-03
Start Date Type:
ACTUAL
Primary Completion Date:
2018-01-21
Primary Completion Date Type:
ACTUAL
Completion Date:
2018-01-21
Completion Date Type:
ACTUAL
First Submit Date:
2014-03-11
First Submit QC Date:
None
Study First Post Date:
2014-03-13
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2018-04-12
Last Update Post Date:
2018-04-13
Last Update Post Date Type:
ACTUAL